Clinical Trials Logo
  1. Home
  2. Pregnancy Loss
  3. NCT01943812
  4. Details
NCT01943812 Clinical Trial

Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation

Pregnancy Loss Clinical Trial

Official title:
Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01943812
Other study ID # Skive-2013-BA
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date December 2013
Est. completion date April 2020

Study information
Verified date June 2020
Source Regionshospitalet Viborg, Skive
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to compare two FET protocols by modifying the substituted FET cycle in order to maintain a higher ongoing positive pregnancy rate and thus reduce the early pregnancy loss.

Hypothesis: adding GnRH-agonist to the substituted cycle in FET treatment reduces the early pregnancy loss.

Recruitment information / eligibility
Status Completed
Enrollment 287
Est. completion date April 2020
Est. primary completion date April 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Endometrial thickness = 7 mm after stimulation

- 18-45 years

- IVF/ICSI fertilisation

- BMI > 18,5 <30 kg/m2

- cycle length 25-34 days

Exclusion Criteria:

- endometrial thickness < 7 mm or no triple layer endometrium and/or functional follicles

- Uterine abnormality

- Chronic medical disease

- oocyte donation cycles

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Estradiol and progeterone
Estradiol and progesterone

Locations
Country Name City State
Denmark IVF syd Fredericia
Denmark Fertility Clinic Regional Hospital Skive Skive

Sponsors (1)
Lead Sponsor Collaborator
Peter Humaidan

Country where clinical trial is conducted

Denmark, 

Outcome
Type Measure Description Time frame Safety issue
Other Luteal progesterone levels 7th week of gestation
Primary Pregnancy loss rate Primary outcome is avaible after 12th week of gestational.
Secondary Pregnancy rate 14 days after embryo transfer.
See also
  Status Clinical Trial Phase
Recruiting NCT00954811 - Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF) Phase 4
Completed NCT00194844 - Couples Miscarriage Healing Project:Randomized Trial Phase 1/Phase 2
Completed NCT03712683 - Thyroxin in Subclinical Hypothyroidism N/A
Not yet recruiting NCT05039853 - Improving Mental Health Following Early PREgnancy Loss Using a Brief Cognitive Task N/A
Withdrawn NCT00771511 - Cervical Capsaicin for Labor Induction and Pain Relief Phase 4
Terminated NCT03100123 - AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study Early Phase 1
Active, not recruiting NCT05108675 - Microbiome and Malnutrition in Pregnancy (MMiP)
Completed NCT03585023 - Infections and Pregnancy Loss: Correlation Between Abortion and Silent Infections.
Completed NCT05430633 - Laparoscopic Versus Open Appendectomy in Pregnancy
Completed NCT00583635 - Early Pregnancy Antioxidant Supplementation in the Prevention of Preeclampsia N/A
Active, not recruiting NCT04360564 - RPL: Interval to Live Birth and Adverse Perinatal Outcomes
Completed NCT03433989 - ACTRAMAT-D: Impact of Post-Traumatic Stress Disorder After Pregnancy Loss After 12 Weeks of Gestation N/A
Terminated NCT03354832 - In-utero Death and Birth Mortality in Reunion Island
Recruiting NCT05284305 - Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy History.
Completed NCT03948022 - Luteal Support in Frozen-Thawed Embryo Transfer Cycles Phase 4
Active, not recruiting NCT05418140 - Adenomyosis and Pregnancy Outcomes in Women Undergoing Assisted Reproductive Technology Treatment
Completed NCT05344144 - EFT and Music on Psychological Development, Well-Being Status and Cortisol Level in Pregnant Women N/A
Recruiting NCT05322252 - Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial Phase 4
Recruiting NCT03775954 - Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
Completed NCT04910958 - Impact of COVID-19 Pandemic on Early Spontaneous Abortions and Early Termination of Pregnancy